Frontera: Pilot project allows foreign-invested businesses to boost CGT development
Companies in these areas are allowed to manufacture and register related products. Approved products can be used by patients nationwide.
Read full article »
CEO
Frontera is a Massachusetts-based biotechnology company that develops and commercializes gene therapy medicines for the treatment of neurology and metabolic diseases.
Read more